论文信息 - Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity. - 字舞流文

Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity.

B. Murphy | J. Blaney | A. Durbin | A. Schmidt | J. McArthur | D. J. Pierro | B. Thumar | Kimberli A Wanionek | S. Whitehead | Jennifer A. Marron